EVMT — Evome Medical Technologies Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapNeutral

Annual cashflow statement for Evome Medical Technologies, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.

	2019 February 28th	2020 February 29th	R2021 February 28th	2022 February 28th	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-0.761	-2.34	-2.67	-4.37	-15.6
Depreciation
Amortisation
Deferred Taxes
Non-Cash Items	0.158	0.865	0.422	0.146	13.1
Discontinued Operations
Unusual Items
Other Non-Cash Items
Changes in Working Capital	4.35	1.29	1.27	-0.206	-0.925
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accrued Expenses
Change in Payable / Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities	4	-0.128	-0.975	-3.7	-0.919
Capital Expenditures	0	—	0	-0.055	-0.203
Purchase of Fixed Assets
Other Investing Cash Flow Items	—	-0.899	0.075	-4.56	-1.32
Acquisition of Business
Sale of Business
Sale/Maturity of Investment
Purchase of Investments
Cash from Investing Activities	0	-0.899	0.075	-4.62	-1.52
Financing Cash Flow Items	0	—	0	-0.66	—
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	0	—	5.43	3.94	0.825
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	3.25	-0.954	4.16	-4.45	-1.01